Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.44B
Enterprise Value4.32B
P/E Ratio90.07
PEG Ratio1.55
Price/Sales Ratio2.22
Price/Book Ratio1.93
Enterprise/Revenue2.15
Enterprise/EBITDA17.13

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.02
Operating Margin0.03
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue2.91B
Revenue/Share2.42
Gross Profit1.19B
EBITDA438.29M
Net Income70.56M
Diluted EPS0.07

Balance Sheet

Total Cash856.29M
Total Cash/Share0.79
Total Debt675.4M
Total Debt/Equity0.22
Current Ratio1.41
Book Value Per Share3.53

Price History

52-Week Change25.59
52-Week High8.44
52-Week Low3.68
Moving Average 50 Days5.56
Moving Average 200 Days5.06

Statistics

Average Volume103.83M
Shares Outstanding1.09B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.97
Payout Ratio0.78
Last Split Factor3:2
Last Split DateMarch 13, 2013
AD